Microbiome Sequencing Service Market is Anticipated to Witness High Growth Owing to Rising Investments in Metagenomics Research

 

Microbiome Sequencing Service Market Demand

The microbiome sequencing service market enables characterization of microbial communities present in human body and other environmental samples using next generation sequencing technologies. Microbiome sequencing allows researchers to understand the role of microorganisms in human health and disease. Advantages of microbiome sequencing include providing deeper understanding of microbial diversity, species level profiling and taxonomic classification. The growing need to study gut-brain axis and role of microbiome in various diseases such as cancer, diabetes, obesity has created demand for microbiome sequencing services.

The Global microbiome sequencing service market is estimated to be valued at US$ 4.13 Bn in 2024 and is expected to exhibit a CAGR of 11.% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the microbiome sequencing service are Microbiome Insights Inc., Baseclear B.V., Clinical Microbiomics A/S, Mérieux NutriSciences Corporation, MR DNA, Zymo Research Corporation, Metabiomics Corp., uBiome, Inc., Microbiome Therapeutics Innovation Group, Locus Biosciences, Inc., OpenBiome, Shanghai Ruiyi Biotechnology Co., Ltd., Resphera Biosciences, LLC, Molzym GmbH & Co. KG, BioSpherex LLC, and Diversigen. Metagenomics has witnessed significant research funding in past few years driving opportunities in functional characterization, disease biomarker discovery and drug development using microbiome data. Major companies are expanding globally through acquisitions and partnerships to strengthen their share in the high growth Microbiome Sequencing Service Market Demand.

The rising number of metagenomics projects and multi-omic research initiatives provide key opportunities in microbiome sequencing service market. Companies are focusing on expanding their geographic presence in high growth regions such as Asia Pacific and Europe through acquisitions and collaborations with local research institutes. This will help companies to gain deeper insights on regional microbiomes and their impact on human and environmental health.

Market Drivers and Restrain:

The key driver for microbiome sequencing service market is rising investments in metagenomics research. Metagenomics studies the collective genetic material recovered directly from environmental samples and studies complex microbial communities. With advancement in sequencing technologies, metagenomics provides a culture-independent approach to study whole microbial communities. This has led to surge in grant funding for metagenomics projects from both private and government sources globally. However, requirement of expensive instruments, dedicated bioinformatics support and high capital investment for building integrated sequencing pipelines are some key challenges restraining market growth. Data management and analyzing large sequencing data generated through metagenomics projects is a complex task requiring specialized bioinformatics expertise, which is currently limited. This poses challenge for widespread adoption of microbiome sequencing in clinical research and healthcare applications.

Segment Analysis

The Microbiome Sequencing Service Market is segmented by technology into 16S rRNA sequencing, metagenomics sequencing, and others. 16S rRNA sequencing is dominating the market currently as it is more cost-effective and easy to analyse and interpret the results compared to metagenomics sequencing. Metagenomics sequencing identifies all genetic material in a microbial community, which provides comprehensive insights but is more expensive and complex analysis.

Global Analysis

Regionally, North America holds the largest share in the Microbiome Sequencing Service Market due to growing applications of microbiome therapeutics for chronic disease management. The presence of major players and developed healthcare infrastructure are some key factors supporting market growth. Europe is the second largest region, while Asia Pacific is emerging as the fastest growing regional market owing to increasing R&D investments in microbiome research from pharmaceutical and biotechnology companies and rising awareness of microbiome-based therapies.

Get More Insights On- Microbiome Sequencing Service Market

Explore More Related Topic On- Alcohol Ethoxylates Market

Comments

Post a Comment

Popular posts from this blog

Plasma Fractionation: The Process of Separating Blood Plasma into Useful Components

Image
  Plasma Fractionation What is Plasma Fractionation? Plasma fraction is the process of separating the different components of blood plasma through various physico-chemical processes like molecular size filtration, precipitation, chromatography and crystallization. Blood plasma, the liquid part of blood, contains thousands of proteins, antibodies, clotting factors and other components which help maintain homeostasis in the body. Plasma Fraction enables isolation of specific plasma proteins on a large scale which are then used to manufacture life-saving plasma derived medicines, diagnostics and medical therapies. Methods used in Plasma Fractionation Several specialized techniques are employed for separating the individual components from pooled donor plasma with high precision and purity. These include: - Cryoprecipitation: Based on temperature-dependent solubility, this involves cooling plasma gradually until certain proteins like Plasma Fractionation precipitate out. The su...
Read more

Theranostics: Transforming the Landscape of Personalized Medicine Innovative Approaches and Groundbreaking Advancements

Image
  Theranostics What is Theranostics? Theragnostics refers to an emerging field in medicine that combines therapeutic and diagnostic capabilities into single agents or platforms. The goal of theragnostics is to provide personalized patient care by selecting appropriate targeted therapies and monitoring their effectiveness. This novel approach has the potential to significantly improve treatment outcomes for many illnesses by matching therapies to individual molecular profiles. Theranostic Agents and Theranostics Theranostics relies on the development of agents and technologies that can both detect specific molecular abnormalities and targets within the body as well as deliver targeted therapies to those same areas. Some examples of theranostic platforms currently under investigation include: - Theranostic Nanoparticles: Nanoparticles are being engineered to incorporate both diagnostic imaging agents like fluorophores as well as targeted drug payloads. These "smart particles...
Read more

Mometasone Furoate Market is Anticipated to Witness High Growth Owing to Growing Prevalence of Allergic Diseases

Image
Mometasone Furoate Market Size Mometasone furoate is a synthetic corticosteroid applied topically to treat conditions such as eczema, psoriasis and dermatitis. It works by reducing inflammation and itching of the skin. It comes as a cream or ointment applied to the skin. Mometasone furoate products are used to treat flare-ups and reduce symptoms of allergic skin conditions. Growing prevalence of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis across the world has increased the demand for anti-allergic medications including mometasone furoate products. The Global mometasone furoate market is estimated to be valued at US$ 1467.01 Bn in 2024 and is expected to exhibit a CAGR of 22.% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the mometasone furoate market are Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Lonza Group, Miltenyi Biotec, Takara Bio Group, CellGenix GmbH, FUJIFILM Irvine Scientific, Agilent Technol...
Read more